MORGAN STANLEY - 31 Dec 2025 SCHEDULE 13G Report for Inhibrx Biosciences, Inc. Common Stock (INBX)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
Inhibrx Biosciences, Inc. Common Stock
Symbol
INBX
Shares outstanding
14,625,519 shares
Disclosed Ownership
1,155,416 shares
Ownership
7.9%
Form type
SCHEDULE 13G
Filing time
11 Feb 2026, 13:33:25 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 7.9% 1,155,416 0 1,155,316 Chris O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley Capital Services LLC 6.3% 918,011 0 918,011 Chris O'Hara Authorized Signatory, Morgan Stanley Capital Services LLC